A dual-chamber implantable cardioverter defibrillator (Ovatio DR) has been released on the European market; the EU has approved an automated stem-cell system (Celution); and Japan has approved a minimally invasive hemodynamic monitoring device (FloTrac Sensor).
Medscape Medical News
Yael Waknine


Click Here to read the entire article...